|
WO2021072359A1
|
|
Manufacture method for aqueous formulation of manganese-containing coordination complex, formulation and method of treatment
|
|
CN111902147A
|
|
Combination cancer therapy of pentaazamacrocycle complexes and platinum-based anticancer agents
|
|
MX2019012259A
|
|
Combination cancer immunotherapy with pentaaza macrocyclic ring complex.
|
|
AU2018221043A1
|
|
Pentaaza macrocyclic ring complexes for local intestinal delivery
|
|
JP2019131508A
|
|
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
|
WO2018045348A2
|
|
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
|
|
KR20180132939A
|
|
Combination therapy for cancer treatment
|
|
EP3388082A1
|
|
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
MX2018001605A
|
|
Pentaaza macrocyclic ring complexes possessing oral bioavailability.
|
|
EP2056675A2
|
|
Methods of treating oral mucositis
|
|
EP2988125A1
|
|
Manganese(ii) pentaazacycloalkane complexes
|
